APA

Landry M. L., Stanat S., Biron K., Brambilla D., Britt W., Jokela J., Chou S., Drew W. L., Erice A., Gilliam B., Lurain N., Manischewitz J., Miner R., Nokta M., Reichelderfer P., Spector S., Weinberg A., Yen-Lieberman B. & Crumpacker C. (20000403). A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates. : Antimicrobial agents and chemotherapy.

Chicago

Landry M L, Stanat S, Biron K, Brambilla D, Britt W, Jokela J, Chou S, Drew W L, Erice A, Gilliam B, Lurain N, Manischewitz J, Miner R, Nokta M, Reichelderfer P, Spector S, Weinberg A, Yen-Lieberman B and Crumpacker C. 20000403. A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates. : Antimicrobial agents and chemotherapy.

Harvard

Landry M. L., Stanat S., Biron K., Brambilla D., Britt W., Jokela J., Chou S., Drew W. L., Erice A., Gilliam B., Lurain N., Manischewitz J., Miner R., Nokta M., Reichelderfer P., Spector S., Weinberg A., Yen-Lieberman B. and Crumpacker C. (20000403). A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates. : Antimicrobial agents and chemotherapy.

MLA

Landry M L, Stanat S, Biron K, Brambilla D, Britt W, Jokela J, Chou S, Drew W L, Erice A, Gilliam B, Lurain N, Manischewitz J, Miner R, Nokta M, Reichelderfer P, Spector S, Weinberg A, Yen-Lieberman B and Crumpacker C. A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates. : Antimicrobial agents and chemotherapy. 20000403.